Unknown

Dataset Information

0

The Development of FAK Inhibitors: A Five-Year Update.


ABSTRACT: Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for both pharmaceutical companies and academia. This review is focused on compounds able to block FAK with different potencies and with different mechanisms of action, that have appeared in the literature since 2017. Furthermore, new emerging PROTAC molecules have appeared in the literature. This summary could improve knowledge of new FAK inhibitors and provide information for future investigations, in particular, from a medicinal chemistry point of view.

SUBMITTER: Spallarossa A 

PROVIDER: S-EPMC9223874 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Development of FAK Inhibitors: A Five-Year Update.

Spallarossa Andrea A   Tasso Bruno B   Russo Eleonora E   Villa Carla C   Brullo Chiara C  

International journal of molecular sciences 20220607 12


Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for both pharmaceutical companies and academia. This review is focused on compounds able to block FAK with different potencies and with different mechanisms  ...[more]

Similar Datasets

| S-EPMC8659154 | biostudies-literature
| S-EPMC7967197 | biostudies-literature
2021-08-24 | GSE182618 | GEO
| S-EPMC10590827 | biostudies-literature
| S-EPMC7664427 | biostudies-literature
| S-EPMC7287747 | biostudies-literature
| S-EPMC10148018 | biostudies-literature
2023-04-26 | PXD039254 | Pride
2023-04-26 | PXD039215 | Pride
2025-05-06 | PXD039828 | Pride